Détail de l'auteur
Auteur L. LIU |
Documents disponibles écrits par cet auteur (5)
Ajouter le résultat à votre sélection Faire une suggestion Affiner la recherche
R. L. COLLINS ; P. C. VINCENT ; J. YU ; L. LIU ; L. H. EPSTEIN | 2014
Dans Experimental and Clinical Psychopharmacology (Vol.22, n°3, June 2014) Article : PériodiqueIn the United States, marijuana is the most commonly used illicit drug. Its prevalence is growing, particularly among young adults. Behavioral economic indices of the relative reinforcing efficacy (RRE) of substances have been used to examine th[...]S. CALVERT ; M. GOLDSZMIDT ; L. LIU ; S. BURM ; S. CRISTANCHO ; J. TORTI ; J. SUKHERA | 2023
Dans Drugs: Education, Prevention and Policy (Vol.30, n°6, December 2023) Article : PériodiqueIn recent years, hospitals have experienced alarming increases in admissions of people who inject drugs (PWID), which present unique challenges to the care process. Untangling the complexity of care can be difficult due to interactions that occu[...]K. M. COLLINS ; R. F. ARMENTA ; J. CUEVAS-MOTA ; L. LIU ; S. A. STRATHDEE ; R. S. GARFEIN | 2016
Dans Substance Abuse (Vol.37, n°4, 2016) Article : PériodiqueBACKGROUND: New and innovative methods of delivering interventions are needed to further reduce risky behaviors and increase overall health among persons who inject drugs (PWID). Mobile health (mHealth) interventions have potential for reaching [...]L. LIU ; C. A. VISHER | 2021
Dans Journal of Drug Issues (Vol.51, n°2, April 2021) Article : PériodiqueStudies show that the deterioration of family bonds and financial difficulty are barriers to a successful reintegration after incarceration. However, how family, community, and correction agencies simultaneously affect individuals' illicit drug [...]B. A. JOHNSON ; N. AIT-DAOUD ; X. Q. WANG ; J. K. PENBERTHY ; M. A. JAVORS ; C. SENEVIRATNE ; L. LIU | 2013
Dans JAMA Psychiatry (Vol.70, n°12, December 2013) Article : PériodiqueIMPORTANCE: No medication has been established as an efficacious treatment for cocaine dependence. We hypothesized that dual modulation of the mesocorticolimbic dopamine system by topiramate-a glutamate receptor antagonist and.-aminobutyric acid[...]